3004.90.92.29/Ibuprofen Suspension for Teething Pain/Canada

Ibuprofen Suspension for Teething Pain from Canada

Specialty oral suspension marketed for infant teething discomfort, containing ibuprofen in dye-free formula. Meets 3004.90.92.29 criteria as retail-packaged, measured-dose NSAID analgesic in suspension.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Pediatric-specific labeling must include weight-based dosing instructions per FDA import rules

• Test for microbial contamination common in suspensions; provide sterility test results